Journal profile · RHEUMATOLOGY
Arthritis Care & Research
ISSN 2151-464X · eISSN 2151-4658 · John Wiley and Sons Inc. · UNITED STATES · Founded 2010
Arthritis Care & Research: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 4.07; hybrid open access; APC about USD 4,640; median 149 days to acceptance (102 articles, last 24 months); acceptance rate 21% (journal website); 261 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Arthritis Care & Research is published by John Wiley and Sons Inc. and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Rheumatoid Arthritis Research and Therapies, Osteoarthritis Treatment and Mechanisms and Spondyloarthritis Studies and Treatments, together about 41.8% of its articles. Its main subfields are Rheumatology. (generated from OpenAlex topic counts and CAS ranking data)
Arthritis Care & Research, an official journal of the American College of Rheumatology and the Association of Rheumatology Professionals (a division of the College), is a peer-reviewed publication that publishes original research, review articles, and editorials that promote excellence in the clinical practice of rheumatology. Relevant to the care of individuals with rheumatic diseases, major topics are evidence-based practice studies, clinical problems, practice guidelines, educational, social, and public health issues, health economics, health care policy, and future trends in rheumatology practice. The American College of Rheumatology (www.rheumatology.org) is the leading professional organization dedicated to the study, prevention, and treatment of debilitating disorders of the joints, muscles, and bones. Members of ACR/ARP can access this journal online. If it is your first time accessing as a member subscriber, go to the member registration form. If you have already registered and linked your account, simply log in to enable your access. The full text of this journal is available online via Wiley Online Library, and includes a wide range of features and services. Abstracting and Indexing Information Embase (Elsevier) Health & Medical Collection (ProQuest) Health Research Premium Collection (ProQuest) HEED: Health Economic Evaluations Database (Wiley-Blackwell) MEDLINE/PubMed (NLM) ProQuest Central (ProQuest) ProQuest Central Basic (Korea) (ProQuest) ProQuest Central Essentials (ProQuest) ProQuest Central Student (ProQuest) Publicly Available Content Database (ProQuest) Science Citation Index Expanded (Clarivate Analytics)
From the journal's Aims & Scope
Research area (LetPub): RHEUMATOLOGY
Editor-in-chief Kelli D. AllenPublisher website
Editorial board by country: 2 in mainland China (about 22%); most named Canada 3, Mainland China 2, United Kingdom 2, Australia 1, Chile 1 (9 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Rheumatoid Arthritis Research and TherapiesMedicine23.7%
- Osteoarthritis Treatment and MechanismsMedicine10%
- Spondyloarthritis Studies and TreatmentsMedicine8%
- Systemic Lupus Erythematosus ResearchMedicine7.9%
- Autoimmune and Inflammatory Disorders ResearchMedicine6.2%
- Total Knee Arthroplasty OutcomesMedicine6%
- Systemic Sclerosis and Related DiseasesMedicine4.8%
- Musculoskeletal pain and rehabilitationMedicine3.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Rheumatology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Rheumatology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Rheumatology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbasePublisher website
Other: ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.07LetPub ·
- Impact factor (publisher)
- 4.1Publisher website ·
- Impact factor (publisher) 2025
- 4.1Publisher website ·
- CiteScore 2026-06
- 8.2LetPub ·
- CiteScore (publisher)
- 8.2Publisher website ·
- CiteScore (publisher) 2025
- 8.2Publisher website ·
- SJR 2026-06
- 1.61LetPub ·
- SNIP 2026-06
- 1.51LetPub ·
- h-index
- 141LetPub ·
- h-index
- 228OpenAlex ·
- i10-index
- 4,163OpenAlex ·
- 2-year mean citedness
- 3.04OpenAlex ·
- Self-citation rate
- 7.3%LetPub ·
- Share of gold OA articles
- 27.84%LetPub ·
Volume
- Articles per year
- 148LetPub ·
- Articles per year (publisher)
- 2Publisher website ·
- Articles per year (publisher) 2025
- 188Publisher website ·
- Downloads per year (publisher) 2025
- 1,663,171Publisher website ·
Articles by year OpenAlex count · 6,650 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 195 | 126 | 41 |
| 2025 | 261 | 198 | 590 |
| 2024 | 218 | 171 | 1,415 |
| 2023 | 216 | 166 | 2,269 |
| 2022 | 209 | 129 | 2,800 |
| 2021 | 273 | 151 | 5,284 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
149 daysMedian, submission to acceptance · P25–P75 100 days – 200 days
- Acceptance to online
- median 50 days (102 articles)
- Submission to online
- median 202 days
- Sample
- 102 articles with submission and acceptance dates (507 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–6 weeksLetPub ·
- Acceptance rate (publisher)
- 21%Publisher website ·
- Acceptance rate (publisher) 2025
- 21%Publisher website ·
- Submission to first decision
- 5 daysPublisher website ·
- Submission to first decision 2025
- 5 daysPublisher website ·
- Submission to acceptance 2025
- 142 daysPublisher website ·
- Acceptance to publication 2025
- 68 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,640 / EUR 3,870 / GBP 3,090 | — | — | |
| Publisher website | USD 500 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Other fees
- USD 500
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Suggested reviewers
- Required
- Not considered
- preprint
Article types accepted7, with length limits
- brief reportReferences, Tables, and Figure Legends. Brief reports should not exceed 2,500 words from introduction through discussion. The total number of tmain text ≤ 2,500 words · abstract ≤ 250 words
- clinicopathologic conference (cpc)Clinicopathologic Conferences (CPC)Length not stated
- letter to the editorLetters to the EditorLength not stated
- letters to the editorLetters to the Editor should be limited to commentaries on previous articles published in Arthritis Care & Research and issues affecting rheumatology and the Am…Length not stated
- narrative reviewr clinical care and/or future research. Narrative Review Articles should not exceed 5,000 words from introduction through discussion (not including referenmain text ≤ 5,000 words
- original articleReferences, Tables, and Figure Legends. Original Articles should not exceed 4,200 words from introduction through discussion (not including referenmain text ≤ 4,200 words · abstract ≤ 250 words
- review articleReview Articles are discussions of clinical or public-health related topics in the rheumatic diseases. Review Articles should provide meaningful messages regard…main text ≤ 5,000 words · abstract ≤ 250 words · references ≤ 85
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Plagiarism, Preprints, Trial registration / reporting guidelines
- Authorship Authorship criteria
Authors. At the time a manuscript under consideration is sent for revision, the corresponding author must provide a listing of each co-author’s contributions, in accordance with the journal’s criteria for authorship, and the journal may publish this information. A downloadable form, in Microsoft Word, is provided on the manuscript submission site to assist corresponding authors in compiling the in…
Source ↗Publisher website ·- Conflicts of interest Disclosure of interest
The journal uses the International Committee of Medical Journal Editors (ICMJE) disclosure of interest form to collect all author disclosures prior to acceptance. For revised manuscripts, the corresponding author should collect a completed ICMJE disclosure of interest form from each co-author, combine all individual forms into a single PDF file and upload the combined file with the manuscript file…
Source ↗Publisher website ·- Data availability Data Sharing Policy
Data sharing statement required Model summary
Authors are required to provide a Data Sharing Statement to be published along with accepted manuscripts. This statement should indicate if data will or will not be shared. The manuscript submission system includes specific questions regarding data sharing. The following options can be selected by authors: No data were used in this article; No data other than what is included in this article or su…
Source ↗Publisher website ·- Publication ethics
ICMJE Recommendations Model summary
Arthritis Care & Research follows the International Committee of Medical Journal Editors Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals: http://www.icmje.org/recommendations/.
Source ↗Publisher website ·- License & copyright Copyright: Wiley Online Licensing Service
Upon acceptance of a manuscript (except letters to the editor and replies, which are exempt), the corresponding author will receive an email with a link to the Copyright: Wiley Author Licensing Service, where he/she must promptly complete and electronically sign the appropriate copyright and/or license agreement. The article will not be published in an issue if this has not been done. If your pape…
Source ↗Publisher website ·- Open access For authors choosing open access
If the open access option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):Creative Commons Attribution Non-Commercial License OAACreative Commons Attribution Non-Commercial No-Derivs License OAAArthritis Care & Research offers authors an open access publication option. You can read more about article publication charges…
Source ↗Publisher website ·- Plagiarism Plagiarism detection
This journal uses iThenticate's CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works. Back to Top
Source ↗Publisher website ·- Preprints
Preprint policy Model summary
Publication on a preprint server is not considered to be prior publication, and the journal accepts the submission of manuscripts that have been previously posted on a preprint server.
Source ↗Publisher website ·- Trial registration / reporting guidelines
Clinical trial registration Model summary
All clinical trials must be registered at www.clinicaltrials.gov, www.controlled-trials.com, or another appropriate national body before they will be considered for publication in Arthritis Care & Research.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- John Wiley and Sons Inc.
- Country or region
- UNITED STATES
- Language
- English
- Founded
- 2010
- ISSN
- 2151-464X
- Electronic ISSN
- 2151-4658
- Society / sponsor
- American College of Rheumatology and the Association of Rheumatology Health Professionals
- Latest issue on the website
- Volume 78, Issue 9 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Arthritis Care & Research
What CAS zone is Arthritis Care & Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, Arthritis Care & Research is in Zone 2 of Medicine, and in Zone 3 of the minor category Rheumatology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Arthritis Care & Research?
The latest impact factor listed by LetPub is 4.07; CiteScore 8.2, h-index 228.
How long does peer review take at Arthritis Care & Research?
Based on the dates recorded on 102 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 149 days (interquartile range 100–200 days); authors report an average review time of 3–6 weeks; the journal's website gives an acceptance rate of 21% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Arthritis Care & Research based?
Of the 9 board members whose country the journal's board page names, 2 (about 22%) are in mainland China; the countries named most often are Canada (3), Mainland China (2) and United Kingdom (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Arthritis Care & Research?
According to LetPub and DOAJ records, Arthritis Care & Research is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed and Embase; that list has not been checked against each database.
Is Arthritis Care & Research open access, and what is the APC?
Arthritis Care & Research is a hybrid journal. For open-access publication: APC about USD 4,640.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .